xmlui.ArtifactBrowser.ConfigurableBrowse.title.metadata.authorArtikkelit"Salmikangas, Paula"

Viitteet 1-7 / 7

Advanced Therapy Medicinal Products: How to Bring Cell-Based Medicinal Products Successfully to the Market : Report from the CAT-DGTI-GSCN Workshop at the DGTI Annual Meeting 2014

Salmikangas, Paula; Celis, Patrick; Ferry, Nicholas; Hystad, Marit; Schüßler-Lenz, Martina; Doevendans, Pieter A.; Flory, Egbert; Beuneu, Claire; Reischl, Ilona
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur̈ Transfusionsmedizin und Immunham̈atologie : 3 (Karger, 2015)
Cell-based therapies for cardiac repair : A meeting report on scientific observations and European regulatory viewpoints

Schüssler-Lenz, M.; Beuneu, C.; Menezes-Ferreira, M.; Jekerle, V.; Bartunek, J.; Chamuleau, S.; Celis, P.; Doevendans, P.; O'Donovan, M.; Hill, J.; Hystad, M.; Jovinge, S.; Kyselovic, J.; Lipnik-Stangelj, M; Maciulaitis, R.; Prasad, K.; Samuel, A.; Tenhunen, Olli; Tonn, T.; Rosano, G.; Zeiher, A.; Salmikangas, Paula
European Journal of Heart Failure : 2 (John Wiley and Sons, 01.02.2016)
Cell-based therapies for cardiac repair: a meeting report on scientific observations and European regulatory viewpoints

Salmikangas, Paula; Schüssler-Lenz, Martina; Beuneu, Claire; Menezes-Ferreira, Margarida; Jekerle, Veronika; Bartunek, Jozef; Hystad, Marit; Jovinge, Stefan; Kyselovič, Ján; Lipnik-Stangelj, Metoda; Maciulaitis, Romaldas; Prasad, Krishna; Samuel, Anthony; Tenhunen, Olli; Torsten, Tonn; Rosano, Giuseppe; Zeiher, Andreas
European Journal of Heart Failure : 2 (Elsevier Science, 2016)
Clinical Development and Commercialization of Advanced Therapy Medicinal Products in the European Union : How Are the Product Pipeline and Regulatory Framework Evolving?

Boráň, Tomáš; Menezes-Ferreira, Margarida; Reischl, Ilona; Celis, Patrik; Ferry, Nicolas; Krafft, Hartmut; Gänsbacher, Bernd; di Lipucci, Paola Michele; Sladowski, Dariusz; Salmikangas, Paula
Human Gene Therapy Clinical Development : 3 (Mary Ann Liebert, 01.09.2017)

The research and development of advanced therapy medicinal products (ATMPs) has been active in Europe and worldwide during recent years. Yet, the number of licensed products remains low. The main expected legal change in ...
Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use

Salmikangas, Paula; Menezes-Ferreira, Margarida; Reischl, Ilona; Tsiftsoglou, Asterios; Kyselovic, Jan; Borg, John Joseph; Ruiz, Sol; Flory, Egbert; Trouvin, Jean-Hugues; Celis, Patrick; Ancans, Janis; Timon, Marcos; Pante, Guido; Sladowski, Dariusz; Lipnik-Stangelj, Metoda; Schneider, Christian K.
Regenerative medicine : 1 (Future Medicine, 2015)
Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective

Salmikangas, Paula; Ruiz, S; Schuessler-Lenz, M; Celis, P; Reischl, I; Menezes-Ferreira, M; Flory, E; Renner, M; Ferry, N
Advances in experimental medicine and biology (Kluwer Academic/Plenum Publishers, 2015)
Report of the International Regulatory Forum on Human Cell Therapy and Gene Therapy Products

Hayakawa, T; Harris, I; Joung, J.; Kanai, N; Kawamata, S.; Kellathur, S; Koga, J; Lin, Y.-C.; Maruyama, Y; McBlane, J; Nishimura, T; Renner, M; Ridgway, A; Salmikangas, Paula; Sakamoto, N; Sato, D.; Sato, Y.; Toda, Y.; Umezawa, A; Werner, M; Wicks, S.
Biologicals : 5 (Academic Press, 01.09.2016)

Artikkelit - Selaus tekijän mukaan "Salmikangas, Paula"

Advanced Therapy Medicinal Products: How to Bring Cell-Based Medicinal Products Successfully to the Market : Report from the CAT-DGTI-GSCN Workshop at the DGTI Annual Meeting 2014 ﻿

Cell-based therapies for cardiac repair : A meeting report on scientific observations and European regulatory viewpoints ﻿

Cell-based therapies for cardiac repair: a meeting report on scientific observations and European regulatory viewpoints ﻿

Clinical Development and Commercialization of Advanced Therapy Medicinal Products in the European Union : How Are the Product Pipeline and Regulatory Framework Evolving? ﻿

Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use ﻿

Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective ﻿

Report of the International Regulatory Forum on Human Cell Therapy and Gene Therapy Products ﻿

Advanced Therapy Medicinal Products: How to Bring Cell-Based Medicinal Products Successfully to the Market : Report from the CAT-DGTI-GSCN Workshop at the DGTI Annual Meeting 2014

Cell-based therapies for cardiac repair : A meeting report on scientific observations and European regulatory viewpoints

Cell-based therapies for cardiac repair: a meeting report on scientific observations and European regulatory viewpoints

Clinical Development and Commercialization of Advanced Therapy Medicinal Products in the European Union : How Are the Product Pipeline and Regulatory Framework Evolving?

Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use

Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective

Report of the International Regulatory Forum on Human Cell Therapy and Gene Therapy Products